201
Participants
Start Date
April 30, 2015
Primary Completion Date
October 31, 2017
Study Completion Date
December 31, 2017
Teneligliptin
Subjects will visit the center on Week 4, 12 and 24 during the entire 24-week treatment period. Total study duration will be approximately 28weeks and the subjects will be to practice exercise/diet control together.
Samsung Medical Center, Seoul
Lead Sponsor
Handok Inc.
INDUSTRY